BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11756184)

  • 1. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines.
    Charrad RS; Gadhoum Z; Qi J; Glachant A; Allouche M; Jasmin C; Chomienne C; Smadja-Joffe F
    Blood; 2002 Jan; 99(1):290-9. PubMed ID: 11756184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.
    Gadhoum Z; Delaunay J; Maquarre E; Durand L; Lancereaux V; Qi J; Robert-Lezenes J; Chomienne C; Smadja-Joffe F
    Leuk Lymphoma; 2004 Aug; 45(8):1501-10. PubMed ID: 15370200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1.
    Gadhoum Z; Leibovitch MP; Qi J; Dumenil D; Durand L; Leibovitch S; Smadja-Joffe F
    Blood; 2004 Feb; 103(3):1059-68. PubMed ID: 14525786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells.
    Allouche M; Charrad RS; Bettaieb A; Greenland C; Grignon C; Smadja-Joffe F
    Blood; 2000 Aug; 96(3):1187-90. PubMed ID: 10910943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells.
    Maquarre E; Artus C; Gadhoum Z; Jasmin C; Smadja-Joffe F; Robert-Lézénès J
    Leukemia; 2005 Dec; 19(12):2296-303. PubMed ID: 16208414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.
    Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia.
    Charrad RS; Li Y; Delpech B; Balitrand N; Clay D; Jasmin C; Chomienne C; Smadja-Joffe F
    Nat Med; 1999 Jun; 5(6):669-76. PubMed ID: 10371506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 ligation with A3D8 antibody induces apoptosis in acute myeloid leukemia cells through binding to CD44s and clustering lipid rafts.
    Qian H; Xia L; Ling P; Waxman S; Jing Y
    Cancer Biol Ther; 2012 Nov; 13(13):1276-83. PubMed ID: 22895075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells.
    Song G; Liao X; Zhou L; Wu L; Feng Y; Han ZC
    Leuk Res; 2004 Oct; 28(10):1089-96. PubMed ID: 15289023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
    Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
    Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New synergistic combinations of differentiation-inducing agents in the treatment of acute promyelocytic leukemia cells.
    Amanzadeh A; Molla-Kazemiha V; Samani S; Habibi-Anbouhi M; Azadmanesh K; Abolhassani M; Shokrgozar MA
    Leuk Res; 2018 May; 68():98-104. PubMed ID: 29602066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.
    Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K
    J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early apoptosis of HL-60 cells induced by anti-CD44 McAb A3D8 inhibiting ERK1/2-upregulated Bim expression].
    Chang GQ; Wang J; Gao W; Wang RJ; Wang LH; Jin WN; Lin YN; Li HW; Pang TX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):656-60. PubMed ID: 21729544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and mechanisms of anti-CD44 monoclonal antibody A3D8 on proliferation and apoptosis of sphere-forming cells with stemness from human ovarian cancer.
    Du YR; Chen Y; Gao Y; Niu XL; Li YJ; Deng WM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1367-75. PubMed ID: 24257550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
    Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
    Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.